Equities

Shandong Lukang Pharmaceutical Co Ltd

600789:SHH

Shandong Lukang Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.79
  • Today's Change-0.08 / -1.02%
  • Shares traded62.55m
  • 1 Year change+15.24%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shandong Lukang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company's primary products include pharmaceutical preparation products, semi-synthetic antibiotic raw materials, veterinary antibiotics and antibiotic raw materials and others. The Company is also involved in the production and distribution of pharmaceutical intermediates. The Company distributes its products in domestic and overseas markets.

  • Revenue in CNY (TTM)6.28bn
  • Net income in CNY267.79m
  • Incorporated1993
  • Employees6.48k
  • Location
    Shandong Lukang Pharmaceutical Co LtdNo. 88, Deyuan Road, High-Tech ZoneJINING 272000ChinaCHN
  • Phone+86 5 372983174
  • Fax+86 5 372983097
  • Websitehttps://www.lkpc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Ausun Pharmaceutical Co Ltd855.13m272.71m6.61bn1.17k24.222.92--7.730.46040.46041.443.820.28761.213.71728,389.909.179.3812.2912.8454.1453.0931.8927.141.96--0.159223.536.8327.357.8742.0724.3250.50
Shouyao Holdings Co Ltd5.23m-191.79m6.63bn185.00--6.85--1,268.44-1.29-1.290.03526.510.00450.26445.2528,265.68-16.55-37.24-18.01-42.6396.5096.03-3,667.74-2,251.778.49--0.0018--186.18-23.51-6.76--34.59--
Chengdu Easton Biopharmaceuticals Co Ltd1.15bn240.60m6.73bn1.40k27.862.54--5.832.012.019.6522.070.35661.547.73824,469.807.438.729.1510.6477.9285.1020.8419.162.59--0.086126.80-4.567.76-8.0910.9117.99--
Shandong Lukang Pharmaceutical Co Ltd6.28bn267.79m6.98bn6.48k26.681.90--1.110.2920.2926.884.110.71873.546.45967,865.703.212.215.514.0523.5523.414.473.460.73135.390.468931.799.3413.0478.378.81-16.9523.94
Cisen Pharmaceutical Co Ltd4.48bn528.35m7.08bn3.40k13.431.20--1.581.161.169.8613.020.60822.815.651,315,959.007.216.949.028.5657.3356.2711.8510.773.12--0.037333.429.753.2248.920.697-15.1910.72
JiangSu WuZhong Pharmactcl Devlpm Co Ltd2.33bn-95.04m7.18bn1.05k--4.06--3.08-0.1366-0.13663.232.480.55316.072.292,220,525.00-2.31-2.92-4.78-5.3022.4128.14-4.18-5.771.22-0.32320.5063--10.555.655.58---19.08--
Beijing Foyou Pharma Co Ltd3.32bn507.64m7.28bn3.44k14.282.06--2.191.061.066.957.350.74823.469.58967,165.9011.50--14.81--65.14--15.37--2.99--0.0316--3.07--11.36------
Harbin Pharmaceutical Group Co., Ltd.15.67bn449.71m7.34bn9.85k15.931.50--0.46830.18270.18276.341.951.136.353.461,590,093.003.790.741410.201.8926.3023.873.350.72941.0640.410.3930.0011.937.41-14.882.69-5.38--
Data as of May 31 2024. Currency figures normalised to Shandong Lukang Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.74%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Apr 20242.43m0.27%
Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 20231.59m0.18%
China Southern Asset Management Co., Ltd.as of 30 Jun 20231.03m0.12%
Wanjia Asset Management Co., Ltd.as of 31 Dec 2023970.50k0.11%
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023135.00k0.02%
Harvest Fund Management Co., Ltd.as of 31 Dec 2023131.90k0.02%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023127.90k0.01%
HFT Investment Management Co., Ltd.as of 31 Dec 202349.30k0.01%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 202347.20k0.01%
Broad Fund Management Co. Ltd.as of 31 Dec 202328.60k0.00%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.